Showing results (21-30 of 51) with videos related to
Sort By:
Pageof 6
Journal of Dermatological Science|October 12, 2025
Molecular profile of interleukin-17RA blockade by brodalumab in Japanese patients with psoriasis: Results from the ESPRIT studyJames G Krueger, Akimichi Morita, Mona Uchida-Yamada, et al.Frontiers in Immunology|October 2, 2023
Multi-omics segregate different transcriptomic impacts of anti-IL-17A blockade on type 17 T-cells and regulatory immune cells in psoriasis skinJaehwan Kim, Jongmi Lee, Xuan Li, et al.Scientific Reports|August 23, 2020
Obesity and ethnicity alter gene expression in skinJeanne M Walker, Sandra Garcet, Jose O Aleman, et al.The Journal of Investigative Dermatology|September 21, 2017
Reduction of Inflammatory and Cardiovascular Proteins in the Blood of Patients with Psoriasis: Differential Responses between Tofacitinib and Etanercept after 4 Weeks of TreatmentJaehwan Kim, Lewis Tomalin, Julie Lee, et al.Experimental Dermatology|April 30, 2024
Gram-negative anaerobes elicit a robust keratinocytes immune response with potential insights into HS pathogenesisSamuel C Williams, Sandra Garcet, Hong Hur, et al.Journal of Dermatological Science|January 23, 2023
Psoriasis improvements and inflammatory biomarker normalization with secukinumab: the randomized ObePso-S studyAndrew Blauvelt, David M Pariser, Stephen Tyring, et al.The Journal of Investigative Dermatology|July 22, 2024
Hepatocyte Growth Factor Has Unique Functions in Keratinocytes that Differ from those of IL-17A and TNF and May Contribute to Inflammatory Pathways in Hidradenitis SuppurativaNaomi Shishido-Takahashi, Sandra Garcet, Inna Cueto, et al.Cancers|September 14, 2024
The Impact of Melanoma Imaging Biomarker Cues on Detection Sensitivity and Specificity in Melanoma versus Clinically Atypical NeviRosario Agüero, Kendall L Buchanan, Cristián Navarrete-Dechent, et al.Experimental Dermatology|December 13, 2016
Aberrant connective tissue differentiation towards cartilage and bone underlies human keloids in African AmericansJudilyn Fuentes-Duculan, Kathleen M Bonifacio, Mayte Suárez-Fariñas, et al.The Lancet. Rheumatology|January 27, 2024
Safety, tolerability, efficacy, pharmacokinetics, and pharmacodynamics of the oral TYK2 inhibitor PF-06826647 in participants with plaque psoriasis: a phase 1, randomised, double-blind, placebo-controlled, parallel-group studyChristopher Tehlirian, Elena Peeva, Elizabeth Kieras, et al.Pageof 6